Juno and AstraZeneca pair two hot immunotherapies in new cancer study

Juno Therapeutics ($JUNO) and AstraZeneca ($AZN) are joining…

Virtual biotechs a hit with investors and, increasingly, buyers

Biotech venture capitalists have increasingly embraced the virtual…

Big Pharma-backed Dutch immuno-oncology player eyes €100M Nasdaq IPO

A Dutch immuno-oncology player that has received venture funding…

Personal cancer vaccine research ‘exciting’ say experts

Tailor-made cancer vaccines that target unique genetic errors…